| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.62e-05 | 599 | 92 | 11 | GO:0050839 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.71e-04 | 339 | 92 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | actin binding | 3.64e-04 | 479 | 92 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 5.57e-04 | 35 | 92 | 3 | GO:0051019 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-matrix adhesion | 3.10e-07 | 4 | 89 | 3 | GO:0007161 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.20e-05 | 118 | 90 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 9.95e-05 | 107 | 90 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 9.95e-05 | 107 | 90 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 1.52e-04 | 117 | 90 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | basement membrane | 1.84e-04 | 122 | 90 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.27e-04 | 591 | 90 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | Z disc | 4.94e-04 | 151 | 90 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 7.58e-04 | 166 | 90 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 8.37e-04 | 576 | 90 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | anchoring junction | FLNA FNDC1 DST HMCN1 MICALL2 PTPRJ PDLIM7 FMN1 CDHR3 OBSL1 PEAK3 MPRIP | 9.57e-04 | 976 | 90 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | axonal growth cone | 9.61e-04 | 45 | 90 | 3 | GO:0044295 | |
| HumanPheno | Cerebral hemorrhage | 1.24e-05 | 103 | 27 | 6 | HP:0001342 | |
| Domain | FN3 | 3.30e-08 | 199 | 88 | 10 | PS50853 | |
| Domain | FN3_dom | 5.24e-08 | 209 | 88 | 10 | IPR003961 | |
| Domain | fn3 | 7.07e-08 | 162 | 88 | 9 | PF00041 | |
| Domain | - | FLNA FNDC1 NEO1 SDK2 FCRL3 FN1 HMCN1 PTPRJ VASN ATF7IP OBSL1 FNDC4 RELA DCC CD300E EBF4 | 7.13e-08 | 663 | 88 | 16 | 2.60.40.10 |
| Domain | Ig-like_fold | FLNA FNDC1 NEO1 SDK2 FCRL3 FN1 HMCN1 PTPRJ VASN ATF7IP OBSL1 FNDC4 RELA DCC CD300E EBF4 | 1.68e-07 | 706 | 88 | 16 | IPR013783 |
| Domain | FN3 | 2.20e-07 | 185 | 88 | 9 | SM00060 | |
| Domain | ZnF_C2HC | 2.22e-07 | 55 | 88 | 6 | SM00343 | |
| Domain | Znf_CCHC | 2.22e-07 | 55 | 88 | 6 | IPR001878 | |
| Domain | Neogenin_C | 2.19e-05 | 2 | 88 | 2 | IPR010560 | |
| Domain | Neogenin_C | 2.19e-05 | 2 | 88 | 2 | PF06583 | |
| Domain | Ig_E-set | 1.32e-04 | 104 | 88 | 5 | IPR014756 | |
| Domain | CH | 2.50e-04 | 65 | 88 | 4 | SM00033 | |
| Domain | CH | 3.33e-04 | 70 | 88 | 4 | PF00307 | |
| Domain | - | 3.51e-04 | 71 | 88 | 4 | 1.10.418.10 | |
| Domain | CH | 3.91e-04 | 73 | 88 | 4 | PS50021 | |
| Domain | CH-domain | 4.33e-04 | 75 | 88 | 4 | IPR001715 | |
| Domain | Thiol-ester_cl | 6.03e-04 | 8 | 88 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 6.03e-04 | 8 | 88 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 6.03e-04 | 8 | 88 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 6.03e-04 | 8 | 88 | 2 | SM01359 | |
| Domain | - | 6.03e-04 | 8 | 88 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 6.03e-04 | 8 | 88 | 2 | SM01361 | |
| Domain | A2M | 6.03e-04 | 8 | 88 | 2 | SM01360 | |
| Domain | IGc2 | 8.54e-04 | 235 | 88 | 6 | SM00408 | |
| Domain | Ig_sub2 | 8.54e-04 | 235 | 88 | 6 | IPR003598 | |
| Domain | A2M_N | 9.64e-04 | 10 | 88 | 2 | PF01835 | |
| Domain | A2M_N | 9.64e-04 | 10 | 88 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 9.64e-04 | 10 | 88 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 9.64e-04 | 10 | 88 | 2 | PS00477 | |
| Domain | A2M | 9.64e-04 | 10 | 88 | 2 | PF00207 | |
| Domain | A2M_N_2 | 9.64e-04 | 10 | 88 | 2 | IPR011625 | |
| Domain | A2M_comp | 9.64e-04 | 10 | 88 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 9.64e-04 | 10 | 88 | 2 | PF07703 | |
| Domain | A2M_recep | 9.64e-04 | 10 | 88 | 2 | PF07677 | |
| Domain | A2M_comp | 9.64e-04 | 10 | 88 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 9.64e-04 | 10 | 88 | 2 | IPR001599 | |
| Domain | - | 1.40e-03 | 12 | 88 | 2 | 1.50.10.20 | |
| Domain | SEA | 1.93e-03 | 14 | 88 | 2 | SM00200 | |
| Domain | Ig_I-set | 2.05e-03 | 190 | 88 | 5 | IPR013098 | |
| Domain | I-set | 2.05e-03 | 190 | 88 | 5 | PF07679 | |
| Domain | - | 2.21e-03 | 15 | 88 | 2 | 3.30.70.960 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.20e-03 | 18 | 88 | 2 | IPR008930 | |
| Domain | IG | 3.73e-03 | 421 | 88 | 7 | SM00409 | |
| Domain | Ig_sub | 3.73e-03 | 421 | 88 | 7 | IPR003599 | |
| Domain | Semaphorin | 3.95e-03 | 20 | 88 | 2 | IPR027231 | |
| Domain | EPHD | 4.77e-03 | 22 | 88 | 2 | PS51805 | |
| Domain | SEA | 4.77e-03 | 22 | 88 | 2 | PF01390 | |
| Domain | Actinin_actin-bd_CS | 5.21e-03 | 23 | 88 | 2 | IPR001589 | |
| Domain | SEA | 5.21e-03 | 23 | 88 | 2 | PS50024 | |
| Domain | SEA_dom | 5.21e-03 | 23 | 88 | 2 | IPR000082 | |
| Domain | ACTININ_2 | 5.21e-03 | 23 | 88 | 2 | PS00020 | |
| Domain | ACTININ_1 | 5.21e-03 | 23 | 88 | 2 | PS00019 | |
| Domain | EGF_1 | 7.13e-03 | 255 | 88 | 5 | PS00022 | |
| Domain | IPT | 7.14e-03 | 27 | 88 | 2 | SM00429 | |
| Pubmed | FAM90A17 FAM90A19 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.13e-17 | 25 | 95 | 9 | 17684299 | |
| Pubmed | 2.14e-13 | 23 | 95 | 7 | 18602769 | ||
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FN1 FAM90A17 VASN FAM90A19 FAM90A26 FAM90A1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 2.95e-11 | 164 | 95 | 10 | 22967998 |
| Pubmed | 2.27e-06 | 418 | 95 | 9 | 34709266 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.47e-06 | 565 | 95 | 10 | 25468996 | |
| Pubmed | 5.15e-06 | 591 | 95 | 10 | 15231748 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34440706 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23831687 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26654447 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27716118 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 36857168 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21160032 | ||
| Pubmed | 7.66e-06 | 486 | 95 | 9 | 20936779 | ||
| Pubmed | 1.50e-05 | 529 | 95 | 9 | 14621295 | ||
| Pubmed | 1.87e-05 | 118 | 95 | 5 | 30979931 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 11752017 | ||
| Pubmed | Immunohistochemical localization of syndecan-1 in the dental follicle of postnatal mouse teeth. | 2.21e-05 | 3 | 95 | 2 | 17608588 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22001909 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22302993 | ||
| Pubmed | Correlation of BAG-3 and heat shock protein 70 with CD30 expression in T-cell lymphomas. | 2.21e-05 | 3 | 95 | 2 | 24492285 | |
| Pubmed | Differential regulation of myosin X movements by its cargos, DCC and neogenin. | 2.21e-05 | 3 | 95 | 2 | 22349703 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24286317 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 10843775 | ||
| Pubmed | 2.79e-05 | 214 | 95 | 6 | 22199357 | ||
| Pubmed | 2.99e-05 | 130 | 95 | 5 | 12421765 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 9441666 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15494733 | ||
| Pubmed | Myosin X regulates netrin receptors and functions in axonal path-finding. | 4.41e-05 | 4 | 95 | 2 | 17237772 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 22084112 | ||
| Pubmed | miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin. | 4.41e-05 | 4 | 95 | 2 | 27693493 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16244667 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16723533 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 28844984 | ||
| Pubmed | 4.59e-05 | 234 | 95 | 6 | 36243803 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C FLNA DST KMT2B KSR2 PKD1 USP40 CUL9 ADGRL1 ATG2A MADD MPRIP | 4.82e-05 | 1105 | 95 | 12 | 35748872 |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 10704383 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 35924788 | ||
| Pubmed | Developmentally regulated expression of Netrin-1 and -3 in the embryonic mouse molar tooth germ. | 7.34e-05 | 5 | 95 | 2 | 12889066 | |
| Pubmed | 7.60e-05 | 30 | 95 | 3 | 20301299 | ||
| Pubmed | 7.70e-05 | 257 | 95 | 6 | 16335952 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 8.40e-05 | 31 | 95 | 3 | 11431694 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 10908620 | ||
| Pubmed | Vector-capping: a simple method for preparing a high-quality full-length cDNA library. | 1.10e-04 | 6 | 95 | 2 | 16106752 | |
| Pubmed | Simultaneous binding of Guidance Cues NET1 and RGM blocks extracellular NEO1 signaling. | 1.10e-04 | 6 | 95 | 2 | 33740419 | |
| Pubmed | High-resolution linkage map in the vicinity of the host resistance locus Bcg. | 1.10e-04 | 6 | 95 | 2 | 8100801 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 24876346 | ||
| Pubmed | Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates. | 1.10e-04 | 6 | 95 | 2 | 22238077 | |
| Pubmed | The membrane protein MiRP3 regulates Kv4.2 channels in a KChIP-dependent manner. | 1.10e-04 | 6 | 95 | 2 | 20498229 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 9226036 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 26397040 | ||
| Pubmed | Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation. | 1.54e-04 | 7 | 95 | 2 | 12351186 | |
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 12798294 | ||
| Pubmed | Rb/E2F regulates expression of neogenin during neuronal migration. | 1.54e-04 | 7 | 95 | 2 | 21059867 | |
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 8678985 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 9226037 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 1347918 | ||
| Pubmed | 1.81e-04 | 102 | 95 | 4 | 9734811 | ||
| Pubmed | 1.95e-04 | 104 | 95 | 4 | 9205841 | ||
| Pubmed | Floor plate and netrin-1 are involved in the migration and survival of inferior olivary neurons. | 2.05e-04 | 8 | 95 | 2 | 10341242 | |
| Pubmed | Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases. | 2.05e-04 | 8 | 95 | 2 | 26651291 | |
| Pubmed | 2.05e-04 | 8 | 95 | 2 | 19651211 | ||
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 1676979 | ||
| Pubmed | Molecular characterization of a deletion encompassing the splotch mutation on mouse chromosome 1. | 2.62e-04 | 9 | 95 | 2 | 2045114 | |
| Pubmed | 2.77e-04 | 114 | 95 | 4 | 21150319 | ||
| Pubmed | 3.16e-04 | 118 | 95 | 4 | 21078624 | ||
| Pubmed | Transcription is required for establishment of germline methylation marks at imprinted genes. | 3.28e-04 | 10 | 95 | 2 | 19136628 | |
| Pubmed | Cellular mechanotransduction relies on tension-induced and chaperone-assisted autophagy. | 3.28e-04 | 10 | 95 | 2 | 23434281 | |
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 7690138 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 20797700 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 1682057 | ||
| Pubmed | 3.74e-04 | 51 | 95 | 3 | 28185240 | ||
| Pubmed | 3.96e-04 | 52 | 95 | 3 | 26633812 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 3.99e-04 | 226 | 95 | 5 | 37839992 | |
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 4.00e-04 | 11 | 95 | 2 | 15186747 | |
| Pubmed | Analysis of Netrin 1 receptors during inner ear development. | 4.00e-04 | 11 | 95 | 2 | 17616930 | |
| Pubmed | Expression QTL and regulatory network analysis of microtubule-associated protein tau gene. | 4.00e-04 | 11 | 95 | 2 | 19233709 | |
| Pubmed | 4.00e-04 | 11 | 95 | 2 | 29444422 | ||
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 4.79e-04 | 12 | 95 | 2 | 24179230 | |
| Pubmed | 4.79e-04 | 12 | 95 | 2 | 1358796 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 4.83e-04 | 132 | 95 | 4 | 16944949 | |
| Pubmed | 4.86e-04 | 506 | 95 | 7 | 30890647 | ||
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 5.01e-04 | 364 | 95 | 6 | 31391242 | |
| Pubmed | The LMO2 oncogene regulates DNA replication in hematopoietic cells. | 5.46e-04 | 58 | 95 | 3 | 26764384 | |
| Pubmed | 5.65e-04 | 13 | 95 | 2 | 20139419 | ||
| Pubmed | 5.65e-04 | 13 | 95 | 2 | 26257176 | ||
| Pubmed | Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. | 5.65e-04 | 13 | 95 | 2 | 12696059 | |
| Pubmed | 6.03e-04 | 140 | 95 | 4 | 26930384 | ||
| Pubmed | Defining brain wiring patterns and mechanisms through gene trapping in mice. | 6.58e-04 | 14 | 95 | 2 | 11242070 | |
| Pubmed | 6.58e-04 | 14 | 95 | 2 | 8605874 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 6.64e-04 | 62 | 95 | 3 | 28344315 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.02e-04 | 256 | 95 | 5 | 33397691 | |
| Pubmed | 7.57e-04 | 15 | 95 | 2 | 26395479 | ||
| Pubmed | 7.85e-04 | 549 | 95 | 7 | 38280479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.98e-04 | 398 | 95 | 6 | 35016035 | |
| Pubmed | 8.64e-04 | 16 | 95 | 2 | 27223328 | ||
| Pubmed | 8.64e-04 | 16 | 95 | 2 | 22632726 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 8.64e-04 | 16 | 95 | 2 | 17948866 | |
| Pubmed | 8.64e-04 | 16 | 95 | 2 | 22677559 | ||
| Pubmed | 8.64e-04 | 16 | 95 | 2 | 22036096 | ||
| Pubmed | 8.64e-04 | 16 | 95 | 2 | 29084269 | ||
| Interaction | LGALS1 interactions | 1.10e-05 | 332 | 85 | 9 | int:LGALS1 | |
| Interaction | ARPC3 interactions | 1.23e-05 | 183 | 85 | 7 | int:ARPC3 | |
| Interaction | PDLIM7 interactions | 1.57e-05 | 264 | 85 | 8 | int:PDLIM7 | |
| Interaction | FAM90A26 interactions | 1.76e-05 | 2 | 85 | 2 | int:FAM90A26 | |
| Interaction | SIAH1 interactions | 4.39e-05 | 223 | 85 | 7 | int:SIAH1 | |
| Interaction | TRIB3 interactions | 5.94e-05 | 160 | 85 | 6 | int:TRIB3 | |
| Interaction | TMOD1 interactions | 6.15e-05 | 161 | 85 | 6 | int:TMOD1 | |
| Interaction | MISP interactions | 6.82e-05 | 164 | 85 | 6 | int:MISP | |
| Interaction | GPSM1 interactions | 8.53e-05 | 55 | 85 | 4 | int:GPSM1 | |
| Interaction | CDH1 interactions | FLNA DST PTPRJ ANLN PDLIM7 FMN1 VASN PTPRQ BAG3 PKD1 KANK2 MPRIP | 8.82e-05 | 768 | 85 | 12 | int:CDH1 |
| Interaction | HSPB2-C11orf52 interactions | 9.12e-05 | 21 | 85 | 3 | int:HSPB2-C11orf52 | |
| Interaction | ACTN1 interactions | 9.60e-05 | 341 | 85 | 8 | int:ACTN1 | |
| Interaction | MIA interactions | 1.05e-04 | 4 | 85 | 2 | int:MIA | |
| Cytoband | 8p23.1 | FAM90A17 FAM90A19 FAM167A-AS1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 3.90e-11 | 154 | 95 | 9 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A17 FAM90A19 FAM167A-AS1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.60e-09 | 234 | 95 | 9 | chr8p23 |
| Cytoband | 12q21.2 | 7.86e-04 | 20 | 95 | 2 | 12q21.2 | |
| Cytoband | 19p13.2 | 1.35e-03 | 229 | 95 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 2.48e-03 | 129 | 95 | 3 | chr2q35 | |
| GeneFamily | Fibronectin type III domain containing | 1.41e-09 | 160 | 56 | 9 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.39e-04 | 161 | 56 | 5 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 3.23e-04 | 193 | 56 | 5 | 594 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.35e-04 | 9 | 56 | 2 | 1234 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.33e-03 | 394 | 56 | 6 | 471 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.73e-03 | 20 | 56 | 2 | 736 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.91e-03 | 21 | 56 | 2 | 813 | |
| GeneFamily | CD molecules|Mucins | 1.91e-03 | 21 | 56 | 2 | 648 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | ZNF512B SEMA6C FLNA SDK2 FN1 HMCN1 ENTPD6 BAG3 PKD1 OBSL1 FNDC4 ZC3HC1 ADGRL1 KANK2 RAB3IL1 EBF4 | 1.86e-05 | 1228 | 83 | 16 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | FLNA NEO1 LRCH2 HMCN1 INHA ATF7IP BAG3 USP40 OBSL1 IMPACT MUC16 CCDC80 | 2.94e-05 | 740 | 83 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.75e-09 | 193 | 88 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.04e-09 | 199 | 88 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.28e-09 | 200 | 88 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.59e-08 | 174 | 88 | 7 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.15e-08 | 187 | 88 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.10e-07 | 192 | 88 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.13e-07 | 193 | 88 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-07 | 194 | 88 | 7 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-07 | 194 | 88 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.18e-07 | 194 | 88 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-07 | 194 | 88 | 7 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 196 | 88 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 196 | 88 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-07 | 199 | 88 | 7 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-07 | 200 | 88 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 200 | 88 | 7 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-07 | 200 | 88 | 7 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 200 | 88 | 7 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-07 | 200 | 88 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-07 | 200 | 88 | 7 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-07 | 200 | 88 | 7 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.45e-07 | 200 | 88 | 7 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-06 | 177 | 88 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-06 | 177 | 88 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.66e-06 | 182 | 88 | 6 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.77e-06 | 184 | 88 | 6 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-06 | 186 | 88 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-06 | 188 | 88 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 188 | 88 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.13e-06 | 190 | 88 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 88 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-06 | 193 | 88 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-06 | 193 | 88 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 194 | 88 | 6 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 194 | 88 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-06 | 194 | 88 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 194 | 88 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.48e-06 | 195 | 88 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.48e-06 | 195 | 88 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-06 | 196 | 88 | 6 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-06 | 196 | 88 | 6 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-06 | 196 | 88 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.70e-06 | 198 | 88 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.70e-06 | 198 | 88 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 198 | 88 | 6 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.70e-06 | 198 | 88 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | distal-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.78e-06 | 199 | 88 | 6 | d4caf296b6ce22a10b78d0efd4e018d867ccb78a | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-06 | 199 | 88 | 6 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 2.78e-06 | 199 | 88 | 6 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-06 | 199 | 88 | 6 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 199 | 88 | 6 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-06 | 199 | 88 | 6 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-06 | 200 | 88 | 6 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-06 | 200 | 88 | 6 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-06 | 200 | 88 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-06 | 200 | 88 | 6 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.86e-06 | 200 | 88 | 6 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-06 | 200 | 88 | 6 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-06 | 200 | 88 | 6 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-06 | 200 | 88 | 6 | a603e8a999612d523bbce9d0feca9296d4a24c97 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-06 | 200 | 88 | 6 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-06 | 200 | 88 | 6 | 0e1f9e1622e5a0fd814a1e100f79cbca2e0dbfbb | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-06 | 200 | 88 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.86e-06 | 200 | 88 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.65e-05 | 160 | 88 | 5 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 166 | 88 | 5 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.97e-05 | 166 | 88 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 166 | 88 | 5 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.15e-05 | 169 | 88 | 5 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 175 | 88 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.61e-05 | 176 | 88 | 5 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.61e-05 | 176 | 88 | 5 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 177 | 88 | 5 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-05 | 177 | 88 | 5 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.75e-05 | 178 | 88 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 178 | 88 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.83e-05 | 179 | 88 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-05 | 181 | 88 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 2.98e-05 | 181 | 88 | 5 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.98e-05 | 181 | 88 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 3.06e-05 | 182 | 88 | 5 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 3.06e-05 | 182 | 88 | 5 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 182 | 88 | 5 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-05 | 183 | 88 | 5 | ec2af3402b51f11466d2a5783a6b33746b6a7fc9 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-05 | 185 | 88 | 5 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.85e-05 | 50 | 46 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Blood cells and cancer expression clusters. | 2.91e-04 | 407 | 46 | 8 | MODULE_532 | |
| Computational | Genes in the cancer module 459. | 4.27e-04 | 431 | 46 | 8 | MODULE_459 | |
| Computational | Genes in the cancer module 378. | 4.54e-04 | 435 | 46 | 8 | MODULE_378 | |
| Computational | Genes in the cancer module 317. | 4.90e-04 | 440 | 46 | 8 | MODULE_317 | |
| Computational | Genes in the cancer module 255. | 5.69e-04 | 450 | 46 | 8 | MODULE_255 | |
| Computational | Blood cells and cancer expression cancer. | 7.37e-04 | 468 | 46 | 8 | MODULE_179 | |
| Computational | Ovary genes. | 8.80e-04 | 368 | 46 | 7 | MODULE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.25e-03 | 50 | 46 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Disease | selective IgA deficiency disease | 8.68e-06 | 46 | 83 | 4 | EFO_1001929 | |
| Disease | Hyalinosis, Segmental Glomerular | 6.68e-05 | 28 | 83 | 3 | C0086432 | |
| Disease | Focal glomerulosclerosis | 1.43e-04 | 36 | 83 | 3 | C0017668 | |
| Disease | Focal segmental glomerulosclerosis | 3.47e-04 | 10 | 83 | 2 | cv:C0017668 | |
| Disease | Inherited focal segmental glomerulosclerosis | 3.47e-04 | 10 | 83 | 2 | cv:CN327126 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 4.23e-04 | 11 | 83 | 2 | cv:CN043612 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.54e-04 | 53 | 83 | 3 | C4707243 | |
| Disease | verbal-numerical reasoning measurement | 5.20e-04 | 131 | 83 | 4 | EFO_0008394 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 5.98e-04 | 13 | 83 | 2 | cv:C4273714 | |
| Disease | chenodeoxycholate measurement | 8.02e-04 | 15 | 83 | 2 | EFO_0010471 | |
| Disease | nervousness | 9.14e-04 | 16 | 83 | 2 | NCIT_C74532 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 9.14e-04 | 16 | 83 | 2 | C1257877 | |
| Disease | ovulation | 1.30e-03 | 19 | 83 | 2 | GO_0030728 | |
| Disease | Pheochromocytoma | 1.30e-03 | 19 | 83 | 2 | C0031511 | |
| Disease | dilated cardiomyopathy | 1.44e-03 | 20 | 83 | 2 | EFO_0000407 | |
| Disease | coronary artery disease | 1.89e-03 | 1194 | 83 | 10 | EFO_0001645 | |
| Disease | Ureteral obstruction | 2.07e-03 | 24 | 83 | 2 | C0041956 | |
| Disease | unipolar depression, depressive symptom measurement | 2.43e-03 | 26 | 83 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Colorectal cancer | 2.62e-03 | 27 | 83 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.62e-03 | 27 | 83 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.62e-03 | 27 | 83 | 2 | cv:C0009404 | |
| Disease | Alzheimer disease, APOE carrier status | 2.69e-03 | 98 | 83 | 3 | EFO_0007659, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPTERTASRQAPPHI | 101 | Q9Y2D5 | |
| SRIHLVQPPPASTIT | 861 | Q8NHU2 | |
| VTHPRTTPVDPIDRS | 771 | Q96NH3 | |
| TTPLRRAPLTTHPVG | 431 | O94910 | |
| YVSPAITTPRRTTHP | 126 | Q496F6 | |
| IALRSVTLPTHRETP | 506 | Q8WXI4 | |
| PLHTVVLSLPERVEP | 41 | Q9BSQ5 | |
| PVHTTSKRPRVDPVL | 151 | A6NDY2 | |
| LRAPAHFPVPSTRVV | 1406 | Q2TAZ0 | |
| SPSHRPPTTTEVITA | 391 | Q76M96 | |
| PPTTTEVITARRPSV | 396 | Q76M96 | |
| VITSTPASPNRELHP | 161 | Q8TBN0 | |
| FPVHTSVPHTRPETR | 441 | Q68DA7 | |
| PVHTTSKRPRVDPVL | 151 | A6NKC0 | |
| HPATPRPEFTSVIRA | 486 | Q99742 | |
| PITTTFLERHLPSVP | 476 | P27338 | |
| TVTVTAPPERIVHPA | 1071 | O75147 | |
| SPERVRNATSPLTHP | 781 | Q8WXI7 | |
| TTAPLARTHSTVPPR | 9976 | Q8WXI7 | |
| APSRTIPTACVRPTH | 1326 | P43146 | |
| STDKTIRVHVPTDPP | 406 | Q5XUX1 | |
| HTPPVPVSDFRVTVV | 451 | Q12913 | |
| PSPSTPNHRRSQVIE | 291 | Q6WCQ1 | |
| VHSSEEDLRTPPRPV | 1631 | Q8WXG6 | |
| PVHTTSKRPRVDPVL | 151 | Q86YD7 | |
| DVETVPQTHRPTPRA | 7526 | Q03001 | |
| VLPVPSTHIGPRTTR | 46 | Q13976 | |
| KESPARSTPHRTPII | 386 | Q9NQW6 | |
| HAVRTPPRTPNIVTT | 256 | Q6VAB6 | |
| SVHITLTPVRPDRTP | 631 | Q8IY33 | |
| PPISARTPHVATVLR | 516 | Q1X8D7 | |
| TIPADVTPERVPTHI | 41 | Q8IXI2 | |
| PTRRTLHPSSIQVQP | 71 | Q6ZS72 | |
| RVSSLHPEPPETRAS | 231 | Q8NA70 | |
| PAALAPVRPTHSSVR | 431 | O75164 | |
| HLSLPRFAPVVTTPV | 701 | Q9UMN6 | |
| PVHTTSKRPRVDPVL | 151 | P0DV74 | |
| TLRCVPKIRPTTHPT | 156 | Q6ZSS7 | |
| PVHTTSKRPRVDPVL | 151 | P0DV73 | |
| PPIDHGIPITDRRST | 171 | Q9P2X3 | |
| TVLTRHSQPATPTPL | 241 | Q9NR12 | |
| VPSTTSPISTRIPHR | 566 | O15265 | |
| SPISTRIPHRTNSVP | 571 | O15265 | |
| PVHTTSKRPRVDPVL | 151 | P0DV76 | |
| VTFPVRQPRHTAAPT | 131 | Q04941 | |
| TKLTVHVPPRIRSTE | 4161 | Q96RW7 | |
| SPTLGRVTPPSRTTH | 276 | Q9UMZ3 | |
| PVHTTSKRPRVDPVL | 151 | A6NJQ4 | |
| RIHPLPRPEVVSLET | 71 | Q9HBI5 | |
| PIRPTHLGEIPITVT | 821 | Q6YHK3 | |
| RTPVPVSVSHRLPVS | 576 | Q6AI39 | |
| SPVPVTPKSIQRTHR | 856 | Q96AV8 | |
| SELITPHAIRVQTPP | 296 | Q9BQW3 | |
| ATPTSPIRVKVEPSH | 856 | P21333 | |
| HGFRRTTPPTTATPI | 2146 | P02751 | |
| PHPTTIITTTPRPRV | 681 | Q6ZTQ4 | |
| HVPSRLPPRSAATVS | 1256 | Q4ZHG4 | |
| RPPSPVNVTVTHLRA | 46 | Q9H6D8 | |
| SLVAVAPSRHPPRTE | 726 | Q8IZJ3 | |
| VPHASASRPRVTEPI | 296 | O14791 | |
| HRPVTQVTTRLPVPR | 1041 | Q6VMQ6 | |
| VRIPVSHPVLTFRAP | 376 | Q96P31 | |
| PTIVRHIVRPKSAEP | 1421 | O15021 | |
| LASPHPSTEARRPVE | 26 | Q96KT0 | |
| ATPFLVAHTRTRPPS | 211 | P05111 | |
| RVPTQEPTHREPTRQ | 446 | Q63ZY3 | |
| RVSAIHEVPPPRSFT | 2316 | Q8IWT3 | |
| PLHSPSPIRVHTVVD | 286 | O95817 | |
| PVHTTSKRPRVDPVL | 151 | A8MXJ8 | |
| PRSTPQLVRTHEDVP | 881 | Q58EX2 | |
| RPRSVASIHVPSPAV | 686 | Q5VUJ6 | |
| VESPAVTPVSARVPR | 3631 | P98161 | |
| ERSTPLTSMPVRHTP | 1216 | Q685J3 | |
| LTTVHRPLPPSRVIE | 281 | Q96KR7 | |
| TPAPTQSPEEVRRLH | 161 | Q96HP8 | |
| TRPPRETPTLTHETF | 121 | O75354 | |
| ITPHVSRSSTPRESP | 1466 | P0DJD1 | |
| PVHTTSKRPRVDPVL | 151 | A6NNJ1 | |
| AIRPTVAIPHEPVSS | 456 | O75603 | |
| PVHTTSKRPRVDPVL | 151 | D6RGX4 | |
| TRVPEVPSSLHVRPL | 736 | Q92859 | |
| RPVRPHTVEKPVPSS | 811 | Q5JRX3 | |
| ATPRPRETTQLPTTH | 121 | P18827 | |
| PRPSHSRVVSFLVTP | 491 | A0A087X1C5 | |
| PEAASPTTRTRPVTR | 366 | Q86WB0 | |
| DRTVPSTPTLVVPHR | 2131 | P12270 | |
| TTSSVPILDRPHPVS | 976 | Q6ZQQ2 | |
| RASPSHIPSVVVLPI | 806 | Q9H2E6 | |
| PARSATPKVRLVEPH | 561 | O15014 | |
| SRVPPSLPLQEVHVS | 16 | Q5GFL6 | |
| SPRDLPEPRVSTEHT | 496 | P28908 | |
| PSPAIVARTVRILHT | 2401 | P21359 | |
| VPPVTHQPLLTLTSR | 406 | Q9H3T2 | |
| ATVPTTRPVVREPTA | 356 | Q6EMK4 | |
| VTVSRPIAISRHTPP | 306 | Q96KM6 | |
| RAQVHTREPTTYPPV | 86 | Q7Z398 | |
| IRSPPPDHVEVETAR | 791 | Q86YA3 | |
| TVRISLVTKDPPHRP | 71 | Q04206 | |
| RLHRAAPQPSTVVPV | 711 | Q9Y334 | |
| TPARPRAPETSLSIH | 1216 | Q9NVE5 | |
| PVHTTSKRPRVDPVL | 151 | P0DV75 |